Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8 NOK | -4,31% | -19,76% | -93,49% |
Omzet 2024 * | 954 mln. 86,31 mln. 81,06 mln. | Omzet 2025 * | - | Marktkapitalisatie | 288 mln. 26,04 mln. 24,45 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 654 mln. 59,2 mln. 55,6 mln. | Nettowinst (verlies) 2025 * | -140 mln. -12,67 mln. -11,9 mln. | EV/omzet 2024 * | -0,93 x |
Nettoliquiditeiten 2024 * | 1,18 mld. 107 mln. 100 mln. | Nettoliquiditeiten 2025 * | 1,05 mld. 95 mln. 89,22 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
0,51
x | K/w-verhouding 2025 * |
-2,19
x | Werknemers | 26 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 68,97% |
Recentste transcriptie over Ultimovacs ASA
1 dag | -4,31% | ||
1 week | -19,76% | ||
Lopende maand | +0,38% | ||
1 maand | +11,42% | ||
3 maanden | -94,25% | ||
6 maanden | -94,41% | ||
Lopend jaar | -93,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Carlos de Sousa
CEO | Chief Executive Officer | 66 | 01-06-20 |
Director of Finance/CFO | 57 | - | |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leiv Askvig
BRD | Director/Board Member | 67 | 01-01-15 |
Jónas Einarsson
CHM | Chairman | 67 | 26-01-11 |
Henrik Schüssler
BRD | Director/Board Member | 61 | 01-01-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 8 | -4,31% | 337 665 |
18-04-24 | 8,36 | -4,46% | 897 326 |
17-04-24 | 8,75 | -13,37% | 2 863 735 |
16-04-24 | 10,1 | +1,71% | 607 769 |
15-04-24 | 9,93 | -0,40% | 1 185 255 |
Real Time Oslo Bors, 19 april 2024 om 13:34 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-93,49% | 26,1 mln. | |
-1,82% | 41,35 mld. | |
+42,44% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |